NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,072,706 | +41.7% | 182,434 | +55.9% | 0.01% | +50.0% |
| Q2 2023 | $5,695,701 | -32.9% | 117,051 | -23.5% | 0.00% | -33.3% |
| Q1 2023 | $8,489,507 | +117.2% | 152,909 | +57.1% | 0.01% | +100.0% |
| Q4 2022 | $3,908,782 | -29.3% | 97,306 | -22.9% | 0.00% | -25.0% |
| Q3 2022 | $5,530,000 | -45.6% | 126,188 | -56.0% | 0.00% | -50.0% |
| Q2 2022 | $10,170,000 | +33.5% | 286,940 | +53.3% | 0.01% | +60.0% |
| Q1 2022 | $7,616,000 | +22.0% | 187,220 | +180.1% | 0.01% | +66.7% |
| Q4 2021 | $6,241,000 | -52.7% | 66,829 | -43.5% | 0.00% | -57.1% |
| Q3 2021 | $13,182,000 | +32.7% | 118,290 | +35.2% | 0.01% | +16.7% |
| Q2 2021 | $9,933,000 | +101.1% | 87,490 | +79.9% | 0.01% | +100.0% |
| Q1 2021 | $4,939,000 | +161.0% | 48,646 | +156.0% | 0.00% | +200.0% |
| Q4 2020 | $1,892,000 | +212.7% | 19,004 | +126.7% | 0.00% | – |
| Q3 2020 | $605,000 | -74.1% | 8,382 | -82.1% | 0.00% | -100.0% |
| Q2 2020 | $2,336,000 | +60.2% | 46,852 | -4.1% | 0.00% | +100.0% |
| Q1 2020 | $1,458,000 | -19.9% | 48,836 | -9.7% | 0.00% | 0.0% |
| Q4 2019 | $1,821,000 | +3.8% | 54,067 | +1.1% | 0.00% | 0.0% |
| Q3 2019 | $1,754,000 | -32.2% | 53,495 | -43.0% | 0.00% | -50.0% |
| Q2 2019 | $2,586,000 | +1874.0% | 93,787 | +1384.2% | 0.00% | – |
| Q1 2019 | $131,000 | -95.2% | 6,319 | -96.7% | 0.00% | -100.0% |
| Q4 2018 | $2,703,000 | +500.7% | 193,618 | +930.0% | 0.00% | – |
| Q3 2018 | $450,000 | +1084.2% | 18,797 | +368.4% | 0.00% | – |
| Q1 2018 | $38,000 | +1800.0% | 4,013 | +1375.4% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 272 | +177.6% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 98 | -24.6% | 0.00% | – |
| Q2 2017 | $1,000 | – | 130 | +1200.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 10 | -100.0% | 0.00% | – |
| Q4 2016 | $309,000 | +808.8% | 26,393 | +849.4% | 0.00% | – |
| Q2 2016 | $34,000 | -56.4% | 2,780 | -66.2% | 0.00% | – |
| Q1 2016 | $78,000 | +136.4% | 8,230 | +172.9% | 0.00% | – |
| Q4 2015 | $33,000 | – | 3,016 | +301500.0% | 0.00% | – |
| Q3 2015 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |